Abstract

We determined the association between vitamin D status as 25hydroxyvitamin D [25(OH)D] and disease activity in a cohort of 201 Crohn’s Disease (CD) patients in Saskatoon, Canada over three years. The association between high-sensitivity C-reactive protein (hs-CRP) and 25(OH)D and several disease predictors were evaluated by the generalized estimating equation (GEE) over three time-point measurements. A GEE binary logistic regression test was used to evaluate the association between vitamin D status and the Harvey-Bradshaw Index (HBI). The deficient vitamin D group (≤29 nmol/L) had significantly higher mean hs-CRP levels compared with the three other categories of vitamin D status (p < 0.05). CRP was significantly lower in all of the other groups compared with the vitamin D-deficient group, which had Coef. = 12.8 units lower (95% CI −19.8, −5.8), Coef. 7.85 units (95% CI −14.9, −0.7), Coef. 9.87 units (95% CI −17.6, −2.0) for the vitamin D insufficient, adequate, and optimal groups, respectively. The vitamin D status was associated with the HBI active disease category. However, the difference in the odds ratio compared with the reference category of deficient vitamin D category was only significant in the insufficient category (odds ratio = 3.45, p = 0.03, 95% CI 1.0, 10.8). Vitamin D status was inversely associated with indicators of disease activity in Crohn’s disease, particularly with the objective measures of inflammation.

Highlights

  • The prevalence of autoimmune diseases is rapidly increasing around the globe [1]

  • This is the only Inflammatory bowel diseases (IBDs) clinic that refers to the university in Saskatchewan and has available data for Crohn’s disease (CD) patients

  • We found that 35.8%, 37.3%, and 39.4% of patients had CD-related surgery at each of the three time-points, respectively

Read more

Summary

Introduction

The prevalence of autoimmune diseases is rapidly increasing around the globe [1]. Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn’s disease (CD), are among the fastest growing autoimmune diseases in developing and developed countries [1]. Inflammatory bowel disease is characterized by chronic relapsing intestinal inflammation. Dysfunction of the immune system contributes to the improper intestinal inflammatory response in patients with IBD [4]. Crohn’s disease is a disease with a broad spectrum of clinical manifestations, including abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. It is more common in women, and age Nutrients 2017, 9, 1112; doi:10.3390/nu9101112 www.mdpi.com/journal/nutrients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call